CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.
about
In vivo and in vitro genetic evidence of involvement of neuregulin 1 in immune system dysregulationImmune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs.Different maturation cocktails provide dendritic cells with different chemoattractive properties.The role played by alternative splicing in antigenic variability in human endo-parasites.CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection.Differential response of primary and immortalized CD4+ T cells to Neisseria gonorrhoeae-induced cytokines determines the effect on HIV-1 replication.Association of the CCR5 gene with juvenile idiopathic arthritis.Concordance of CCR5 genotypes that influence cell-mediated immunity and HIV-1 disease progression ratesInfluence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian populationThe effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.An aberrant thymus in CCR5-/- mice is coupled with an enhanced adaptive immune response in fungal infection.Distinct patterns of Bcl-2 expression occur in R5- and X4-tropic HIV-1-producing lymphoid tissue cells infected ex vivo.Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation.CCR5 blockade is well tolerated and induces changes in the tissue distribution of CCR5+ and CD25+ T cells in healthy, SIV-uninfected rhesus macaquesMaraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized TrialHIV RNA suppression and immune restoration: can we do better?Bone marrow from blotchy mice is dispensable to regulate blood copper and aortic pathologies but required for inflammatory mediator production in LDLR-deficient mice during chronic angiotensin II infusionEpigenetic mechanisms, T-cell activation, and CCR5 genetics interact to regulate T-cell expression of CCR5, the major HIV-1 coreceptorNon-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints.GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathwaysA pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4⁺ T-cell recovery despite sustained virologic suppression: ACTG A5256.Plasma Inflammatory Factors Are Associated with Anxiety, Depression, and Cognitive Problems in Adults with and without Methamphetamine Dependence: An Exploratory Protein Array Study.CCR5 antagonism impacts vaccination response and immune profile in HIV-1 infectionInflammatory mediator profiling reveals immune properties of chemotactic gradients and macrophage mediator production inhibition during thioglycollate elicited peritoneal inflammation.In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.Effect of maraviroc intensification on HIV-1-specific T cell immunity in recently HIV-1-infected individuals.Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection.The multiple faces of CXCL12 (SDF-1alpha) in the regulation of immunity during health and disease.Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.Lysosomal phospholipase A2: a novel player in host immunity to Mycobacterium tuberculosis.Shikonin Suppresses Human T Lymphocyte Activation through Inhibition of IKK β Activity and JNK PhosphorylationMaraviroc reduces the regulatory T-cell frequency in antiretroviral-naive HIV-infected subjects.Production of LPS-induced inflammatory mediators in murine peritoneal macrophages: neocuproine as a broad inhibitor and ATP7A as a selective regulator.Double-edged genetic swords and immunity: lesson from CCR5 and beyond.In vitro effects of the CCR5 inhibitor maraviroc on human T cell function.Marked differences in CCR5 expression and activation levels in two South African populations.The intensity of immune activation is linked to the level of CCR5 expression in human immunodeficiency virus type 1-infected persons.Pseudolaric acid B suppresses T lymphocyte activation through inhibition of NF-kappaB signaling pathway and p38 phosphorylation.
P2860
Q24610713-9BD9ECB0-127A-4DB1-94E9-BF92C3923D14Q27687272-D6ACF9B7-F759-4695-9F06-8A77C4C64C22Q30315866-57D6D042-6CD0-4757-8701-E2080E0EA2CAQ33588936-2C109D46-579B-426A-80E7-D3CC2E4EE819Q33839741-6B8237E0-B222-4A44-B695-E2859AB3BF62Q33883419-245BFD23-B18D-4E74-A1AF-85AB55DD80C8Q34282309-2D1305FE-0D04-43AD-B134-27C611E8DFC2Q34763459-780D4831-D095-4A0B-8FC5-CAC9452EC893Q34988294-53022BE1-E69E-4EC1-B4A4-24DD2D01A63FQ34994967-5BD2BACF-0664-4BCA-888A-5435B27406F9Q35035564-E7530D9F-D6E6-4E62-A434-B931F0D236EAQ35143430-8AE7E5EA-4BA3-4508-81C9-44A875B97E9CQ35149267-75E47747-D296-4051-8F9F-6E532B4F373DQ35693333-7CA31C8B-8C20-4881-8FD6-160EDEEA2E53Q35712284-AD7AEEE9-8245-4908-BFCA-820C9C38BB1BQ35867173-BCFF54E2-5996-47E0-8EEC-C90AFE5F74B6Q35903447-10B31AE2-4772-46D5-A529-4313698704C5Q36008317-9F166367-49E8-45FB-89E8-BB5A68B6B7AAQ36160526-E2570F9B-B72D-4BD4-9FB0-468B7924719DQ36179796-B06F786F-247A-4EEE-828F-06B1DC85FD34Q36379230-21A625CE-D040-4FA5-8906-26C9B5C84B43Q36381738-79C54DB2-344F-4CEB-AF39-DF6AD17E9A86Q36434337-7648BB44-808D-4307-92CC-81CBCEFAA267Q36771585-B4A64125-DEA4-47A4-BCFB-3E8DB47C5FAFQ36888917-3F5A47FF-460C-487B-A70E-C9DB9444D0A9Q37348497-48958BDF-13EA-42BB-BC26-E318DEE96D82Q37521828-2C97477A-81F1-4D66-B3EC-3CDE49DEBA65Q37668003-E81EE5B5-F368-4FE7-9497-D4C1466AF4E6Q37760665-1260072C-B27F-4A3D-9DF7-A315E7DDC4CEQ38066127-632B02E6-FFEC-44D7-99B5-8BC8A1FB0CA4Q38702121-1A893912-C64C-4285-ADB1-0B94C770A768Q39437874-CC2CF3B4-78CC-40F6-AE9A-17CE4D2B4355Q41428122-7E300B50-45E7-45BF-A25D-31D037702E46Q42222937-16AF7091-502E-4EE9-991B-FE2DC602D7F1Q42711786-4795A826-AF9B-457B-B007-C9EC63D3F86DQ43066917-796A41D0-2862-4CD2-BAE3-85F331ADE23BQ44242057-15671EAD-42A4-41FD-AFCA-42E37C24B85DQ45015137-98A9B3D0-9065-497A-B0A9-809F1DC73172Q45355735-674D41F6-49F8-4AD4-B2F0-02279A460A9EQ45977248-04CCC816-BDBF-4BFA-8E1F-E2608CCBC6A1
P2860
CCR5 expression levels influence NFAT translocation, IL-2 production, and subsequent signaling events during T lymphocyte activation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CCR5 expression levels influen ...... uring T lymphocyte activation.
@ast
CCR5 expression levels influen ...... uring T lymphocyte activation.
@en
CCR5 expression levels influen ...... uring T lymphocyte activation.
@nl
type
label
CCR5 expression levels influen ...... uring T lymphocyte activation.
@ast
CCR5 expression levels influen ...... uring T lymphocyte activation.
@en
CCR5 expression levels influen ...... uring T lymphocyte activation.
@nl
prefLabel
CCR5 expression levels influen ...... uring T lymphocyte activation.
@ast
CCR5 expression levels influen ...... uring T lymphocyte activation.
@en
CCR5 expression levels influen ...... uring T lymphocyte activation.
@nl
P2093
P2860
P1476
CCR5 expression levels influen ...... uring T lymphocyte activation.
@en
P2093
Alvaro A Gaitan
Derya Unutmaz
Fabio Jimenez
Jose F Camargo
Kazi Begum
Marlon P Quinones
Scott VanCompernolle
Seema S Ahuja
Sowmya Srinivas
Srinivas Mummidi
P2860
P304
P356
10.4049/JIMMUNOL.182.1.171
P407
P577
2009-01-01T00:00:00Z